About Justin Stebbing
Justin Stebbing is a director at EtiraRX.
Experience
This experience comes from Justin Stebbing's profile and from SEC filings. For roles taken from filings, the years are when the filings name Justin Stebbing in the role, so the role may have started earlier or lasted longer.
EtiraRX, Inc. Current
Board of Directors of Etira
2024 – Present · Dallas, TX
Develops investigational cancer medicines for patients with advanced or metastatic tumors.
LC
London Lauriston Clinic Current
Consultant Oncologist
2024 – Present
EG
Enhanced Games Current
Scientific Advisor to Enhanced
2024 – Present
PI
Portage Biotech Inc Current
Board Member (December 2024 appointed BoD Chair)
2024 – Present
GB
Graviton Bioscience Current
Senior VP Clinical Strategy and Innovation
2024 – Present
SB
Sable Bio Current
Scientific Advisor to Sable Bio
2024 – Present
LI
LinkGevity Current
Advisory Board Member
2024 – Present
LM
L-Università ta' Malta (University of Malta) Current
Affiliate Professor at the Institute of Space Sciences and Astronomy
2023 – Present
CI
Clinical ink Current
Scientific Advisor to Clinical Ink
2023 – Present
ZA
Zephyr AI Current
Chair of SAB of Zephyr AI
2022 – Present
PG
Phoenix Hospital Group Current
Consultant Oncologist
2022 – Present
ON
Onconox Current
Head of Strategy, Board Member and SAB Chair
2022 – Present
TP
The Listening Place Current
Listening Volunteer
2022 – Present
IL
Imperial College London Current
Visiting Professor
2022 – Present
AU
Anglia Ruskin University Current
Professor of Biomedical Sciences
2021 – Present
VP
Vitruvian Partners Current
Analyst
2020 – Present
GR
Greenmantle Current
Senior Advisor
2020 – Present
SN
Springer Nature Current
Editor In Chief - Oncogene
2016 – Present
LP
Lansdowne Partners Current
Consulting Analyst
2009 – Present
BE
BenevolentAI
Scientific Advisor
2019 – 2024
Key Colleagues at Startups
The people Justin Stebbing works with at each company, as listed on that company's latest Form D.
EtiraRX, Inc. · Form D, May 14, 2026
AJ
Annalisa Jenkins
Director
RH
Russell Hayward
Chief Executive Officer and director
GR
Ganesh Raj
Executive officer and director